OnDosis

OnDosis is developing a novel approach to the administration and delivery of pharmaceuticals through a handheld device that integrates medicine with intelligent dosing and digital capabilities. OnDosis plans to use the new investment to finalise an ongoing drug-device development for the treatment of ADHD, and to initiate new projects in the areas of rare disease and transplantation medicine. The company will also establish a digital platform and scale up its supply chain ahead of a planned FDA filing.